FDA scientists found only rat data on the seven peptides Kennedy's panel votes on this week — and seven advisers sell the products themselves.

The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.

U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry…